We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dr. Reddy’s Launches Allegra Generic

Law360 (April 17, 2006, 12:00 AM EDT) -- India's Dr. Reddy's Laboratories has said it will begin marketing a generic version of the blockbuster allergy drug Allegra in the United States, disregarding a pending patent infringement lawsuit brought by the drug’s developer, Sanofi-Aventis SA.

Although rival generic drug makers Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. began marketing their versions in 2005, demand for the drug appears high enough for an at-risk launch, with Allegra generating about $1 billion in revenue last year.

Dr. Reddy's said it would immediately start marketing fexofenadine, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.